Trial
NCT02922413
Panhematin for Prevention of Acute Attacks of Porphyria
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
The University of Texas Medical Branch, Galveston
Collaborators
—
Condition
Acute Intermittent Porphyria
Intervention
Hemin for injection
Why stopped
Low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-30